|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07D 239/48 | (2006.01) |
| C07D 403/04 | (2006.01) | ||
| C07D 403/12 | (2006.01) | ||
| C07D 413/14 | (2006.01) | ||
| C07D 405/12 | (2006.01) | ||
| C07D 405/14 | (2006.01) | ||
| C07D 471/06 | (2006.01) | ||
| C07D 471/10 | (2006.01) | ||
| C07D 491/10 | (2006.01) | ||
| C07D 491/107 | (2006.01) | ||
| C07F 9/53 | (2006.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 31/505 | (2006.01) | ||
| A61K 31/675 | (2006.01) |
| (11) | Patento numeris | 3205650 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15849629.9 |
| Europos patento paraiškos padavimo data | 2015-09-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-08-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-08-04 |
| (46) | Apibrėžties vertimo paskelbimo data | 2021-09-10 |
| (86) | Numeris | PCT/CN2015/091189 |
| Data | 2015-09-30 |
| (87) | Numeris | WO 2016/054987 |
| Data | 2016-04-14 |
| (30) | Numeris | Data | Šalis |
| 201410534203 | 2014-10-11 | CN |
| (72) |
WEI, Mingsong , CN
SUN, Guangjun , CN
TAN, Songliang , CN
GAO, Peng , CN
WANG, Shaobao , CN
XIU, Wenhua , CN
ZHANG, Fujun , CN
BAO, Rudi , CN
|
| (73) |
Shanghai Hansoh Biomedical Co., Ltd. ,
Building 2
No.3728 Jinke Road
Zhangjiang Hi-Tech Park, Shanghai 201203,
CN
Jiangsu Hansoh Pharmaceutical Group Co., Ltd. , The 10th Industrial Sub-zone of Development Zone Lianyungang, Jiangsu 222047, CN |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | EGFR inhibitorius ir jo gavimas bei taikymas |
| EGFR INHIBITOR, AND PREPARATION AND APPLICATION THEREOF |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-08-28 | 11 | 289.00 EUR |
| 2026-09-30 |